Latest News

Stay up to date with the latest developments in myasthenia gravis research, advocacy, and community support. Explore news, events, and policy updates to stay informed and get involved.

Browse our categories to explore stories relevant to you, and stay connected with the MG community.

All
  • All
  • About MAA News Items
  • Annual Conference News Items
  • Art With Heart News Items
  • Clinical Trials
  • Get Involved News Items
  • Health Professionals News Items
  • Living with MG News Items
  • MG Awareness Month News Items
  • Patient Tool Kit
  • Policy Makers News Items
  • Understanding MG News Items
  • Webinar
MG Connect Patient Symptom Tracker App helping Australians with myasthenia gravis monitor symptoms.
MG Connect Patient Symptom Tracker App now available

Living with myasthenia gravis (MG) can be unpredictable, and symptoms often fluctuate between clinic visits. The MG Connect Symptom Tracker App, developed with input from people living with MG, helps capture day-to-day changes and have more focused conversations with your neurologist. Built around the widely used Activity of Daily Living scale (MG-ADL), the app lets…

MyClad Study clinical trial banner inviting Australians with myasthenia gravis to participate in MG research
MyClad Study – ALL Recruitment Sites are now operating and ready for enquiries.

People living with generalised myasthenia gravis (gMG) who are interested in learning more about clinical research opportunities can now enquire about the MyClad Study, with all recruitment sites and participating hospitals now open for enquiries. The MyClad Study is a clinical research study evaluating an investigational medication taken by mouth for people living with gMG.…

Brain Function and Wellbeing App Survey inviting people living with neurological conditions to help shape a new smartphone app.
Help Shape a New Brain Function and Wellbeing App. Complete a Short Survey by 6 July

Share your feedback by Monday 6 July Researchers from Monash University and Alfred Health are inviting people living with neurological conditions to help shape the development of a new Brain Function and Wellbeing App. The smartphone app is being designed to help people track symptoms, thinking, memory, wellbeing and quality of life over time. It…

Rystiggo (rozanolixizumab) now available on the PBS for eligible Australians living with generalised Myasthenia Gravis.
A new innovative therapy for Myasthenia listed on the PBS

Rystiggo (rozanolixizumab) is now listed on the Pharmaceutical Benefits Scheme (PBS) for generalised Myasthenia Gravis (gMG) patients who are AChR antibody positive.* Rystiggo is the first neonatal Fc receptor (FcRn) inhibitor available via the PBS for our patient community. This is a fantastic milestone for us because it expands our treatment options. In fact, it…

Final days to bid in the Art With Heart Auction 2026 featuring original artwork, handmade gifts and unique donated items supporting Myasthenia Gravis awareness and research.
Final Opportunity: The Art With Heart Auction Closes This Sunday

VIEW THE ART WITH HEART AUCTION >> The countdown is on… After months of planning, creating, donating, sharing and raising awareness, the Art With Heart Auction is now entering its final days. At midnight on Sunday 28 June 2026, bidding will officially close. If you’ve been meaning to take a look, place a bid, or…

Art With Heart Auction 2026 featuring donated artwork and handmade items raising awareness and funds for Myasthenia Gravis research, advocacy and support.
Art With Heart Auction | Bidding Now Open!

VIEW THE ART WITH HEART AUCTION >> What an incredible month it has been for the MG community. Across Australia, MG Awareness Month has sparked a wave of activity, connection and conversation. From partnerships with the Cowboys Rugby League Club and landmark buildings lighting up in support, to guest speakers, community walks and local events,…

Associate Professor Stephen Reddel inviting people with generalised myasthenia gravis in NSW to participate in a clinical trial study.
A message to the Australian MG community and in particular to patients in NSW from Associate Professor Stephen Reddel.

I am writing to let you know that I, Steve Reddel, is taking part as a Principal Investigator in a study for patients with generalized Myasthenia Gravis (gMG). The study is sponsored by Novartis. The study is a multicentre, double-blind, placebo-controlled phase III study of an oral medication in generalised myasthenia gravis patients with ACHR+…

Featured image for the MAA 5th National Patient Conference 2026 in Brisbane
Save the Date! MAA 5th National Patient Conference

The MAA team are preparing to host a 5th National Patient Conference. This will be a very special event hosted at Rydges South Bank in South Brisbane. Hosting at a function centre allows the MAA to make attending much more achievable for many in our community. Auditorium seating is replaced with round tables, lots of…

Reminder graphic for the Speaking Up When Symptoms Change MG webinar by Myasthenia Alliance Australia
Reminder: Join MAA’s Upcoming Webinar on Recognising MG Symptom Changes

Living with myasthenia gravis often means symptoms can change unexpectedly, making it difficult to know when to seek support or start a conversation with your healthcare team. Myasthenia Alliance Australia (MAA) invites you to join our upcoming webinar: Speaking Up When Symptoms Change: Knowing When and How to Reach Out to Your Doctor Presented by…

Art With Heart auction graphic featuring donated artwork supporting myasthenia gravis awareness and research
The Response to Art With Heart Has Been Incredible… But We’re Not Done Yet

The generosity already shown through the Art With Heart campaign has been truly inspiring. With artwork and item donations officially closing on 5 June 2026, now is the final opportunity to contribute to a campaign helping raise awareness and support for people living with myasthenia gravis. Artists, supporters, businesses, and members of the community from…